We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Novel Vaginal Gel Prevents Pregnancy On-Demand

By HospiMedica International staff writers
Posted on 15 Sep 2020
A new non-hormonal gel prevents contraception by keeping vaginal pH levels in a range that is inhospitable to sperm.

The new contraceptive, named Phexxi, a product of Evofem Biosciences (San Diego, CA, USA), developed at the University of Illinois in Chicago (UIC, USA), is based on a combination of lactic acid (1.8%), citric acid (1%), and potassium bitartrate (0.4%). More...
Provided in a pre-filled, ready to use applicator, it works by maintaining the vagina's natural acidic pH level, killing male sperm. To maintain long-term efficacy, Phexxi creates a bioadhesive, viscous layer of gel that coats the vaginal and cervical surfaces, which allows it to remain in place and maintain the acidic environment.

To use Phexxi, the pre-filled applicator and plunger rod are removed from the foil pouch. The plunger rod is inserted into the applicator, and pushed until the two connect. The pink protective cap is then removed. In an appropriate position, the pre-filled applicator is inserted into the vagina as far as it will comfortably go, at which point the plunger rod is pushed until it stops; the single-use delivery device is then disposed of. The gel is effective immediately, delivering a dose of contraceptive gel that lasts up to one hour, which is only effective when used before sex.

“There are any women who feel that hormonal, long-acting birth control is not a viable option, and there are women who struggle to access prescription or implanted birth control due to lack of insurance or access to health care,” said UIC professor of pharmacology Donald Waller, PhD, who developed Phexxi in collaboration with Lourens Zaneveld, PhD, of Rush University Medical Center (Chicago, IL, USA). “There is a need for in-the-moment options that give women control, and I think many women will appreciate that such an option does not rely on steroid hormones. My hope is that women feel empowered with options to protect themselves.”

Vaginal pH levels are crucial to maintaining a healthy environment and preventing bacteria growth. Vaginal pH balance is maintained at a homeostasis between 4 and 4.5 due to Lactobacilli, naturally occurring bacteria that produce lactic acid, which helps reduce the reproduction of alkaline bacteria that can cause bacterial and yeast infections. During intercourse, vaginal pH levels may rise to protect the sperm as it travels towards the egg.

Related Links:
Evofem Biosciences
University of Illinois in Chicago



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new 3D heart mapping system visualizes all four chambers in real time (Photo courtesy of UPV)

Whole-Heart Mapping Technology Provides Comprehensive Real-Time View of Arrhythmias

Cardiac arrhythmias can be difficult to diagnose and treat because current mapping systems analyze the heart one chamber at a time. This fragmented view forces clinicians to infer electrical activity they... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.